The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Professor Karol Sikora
@ProfKarolSikora
·
1h
These antibody tests are so tricky.
Ordering 50 million is great, but we only found 7% of our staff have the antibodies.
You won't get false positives, but there will be lots of false negatives.
Many people fight the virus off without using antibodies - more work to do.
A follow up from yesterday:
https://twitter.com/stockmarketmae1
stockmarket_maestro
@stockmarketmae1
#NCYT #novacyt BOOOOM!! A friend of mine who is an essential worker has ordered the home test kit today via the Gov website. She received an email confirmation with a video attached. She is sure it says #NOVACYT on the video!!will take a photo tomorrow when she receives it!
"and everyone who tests negative could re-enter the economy with confidence"
Not sure that I would be confident as you could easily come into contact with it after being cleared by a test
Gill Benning
@GillBenning
·
2h
We need immediate nebuliser solutions like the one SYNAIRGEN will be releasing to the world in a fanfare soon. Already fast tracked by Prof Chris Whitty as Head of NIHR. Watch this space. #SNG #StockMarket #stockstowatch #London #HealthyAtHome #MondayMorning
https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/RBD/14506284.html
https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/SNG/14505517.html
This is what was probably referred to by CNN:
6 hr 15 min ago
US FDA authorizes new Covid-19 saliva test for emergency use
From CNN's Jacqueline Howard
The US Food and Drug Administration has authorized a saliva test for diagnosing Covid-19 in emergencies.
Rutgers University, where the test was developed in collaboration with other groups, announced the FDA authorization today after formally receiving it over the weekend.
What this means: Using saliva to diagnose novel coronavirus infections could expand testing capacities across the United States. So far, testing for Covid-19 has usually involved nose or throat swabs.
"It means we no longer have to put health care professionals at risk for infection by performing nasopharyngeal or oropharyngeal collections," Andrew Brooks, chief operating officer and director of technology development at the university's RUCDR Infinite Biologics lab, said in a news release.
According to Rutgers University's news release, this is the first such saliva test to receive emergency use authorization from the FDA. Brooks, a professor at the university, called the impact of the authorization "significant."
Across the United States, which has faced a shortage of tests, several other laboratories have been working on developing saliva tests and other types of diagnostic testing for Covid-19.
So far during the coronavirus pandemic, the FDA has worked with more than 300 test developers who have said they plan to submit emergency use authorization requests to the agency for their diagnostic tests, the agency announced on Monday.
According to the FDA, 34 emergency-use authorizations have been issued for diagnostic tests to date.